2024-11-21 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Johnson & Johnson (JNJ), a leading healthcare company developing and selling various medical products and pharmaceuticals, has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for JNJ is 34.24%, while the S&P 500 shows a 125.68% return.  This results in a substantial difference of -91.44%.  The relative divergence of -91.44% places JNJ in the 2.55th percentile of its historical performance range relative to the S&P 500.


**2. Recent Price Movement:**

* **Closing Price:** $153.11
* **5-Day Moving Average:** $153.35
* **20-Day Moving Average:** $157.06
* **60-Day Moving Average:** $161.44

The price is currently below all three moving averages, suggesting a downward trend.

**3. Technical Indicators & Expected Return:**

* **RSI (27.09):** Indicates the stock is in oversold territory, suggesting potential for a bounce.
* **PPO (-0.2):** Shows a negative momentum, aligning with the downward trend.
* **20-Day Relative Divergence (-8.21):**  Confirms a recent short-term downward trend.
* **Expected Return (0.0%):**  The model predicts no significant excess return over the S&P 500 for long-term (2+ years) investments at the current price.  This is consistent with the historical underperformance.  Given the current price of $153.11 is not significantly different from the recent averages, no additional factors related to sharp price swings are considered.


**4. Recent Financial Performance:**

The provided EPS and revenue data show some fluctuation.  While revenue remains relatively stable around $22B, EPS shows variability.  Missing is the expected EPS for the most recent quarter (2024-10-23), which would be crucial for a complete analysis. A comparison of actual versus expected EPS for the most recent quarter is needed for a comprehensive assessment of performance against market expectations.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Shows consistently high profit margins (around 69%), indicating strong profitability. Revenue is relatively stable, suggesting consistent performance.

* **Capital and Profitability:** ROE fluctuates, with a notably high value of 36.54% in 2023-09-30.  This outlier warrants further investigation to determine the cause.  Overall, the equity remains fairly stable.

**6. News and Recent Issues:**

*(This section requires real-time data.  Please provide links to recent news articles or financial reports for a comprehensive analysis.  I cannot access real-time information, including news from sources like Shacknews or FINBOLD.)*  A search for recent news (within the past two days) related to JNJ's earnings announcements and market outlook is needed to complete this section. Analyst opinions and performance highlights should be included here.

**7.  Comprehensive Analysis:**

JNJ has significantly underperformed the S&P 500 recently. While profitability and revenue remain strong, the stock's recent price action and technical indicators suggest a bearish trend.  The low RSI suggests potential for a short-term rebound, but the negative PPO and downward moving averages point to a continuation of the downtrend.  The low expected return relative to the S&P 500 and the significant underperformance against the market highlight a need for caution before investing.  A thorough review of the latest earnings report, particularly comparing actual to expected EPS, is crucial. Further analysis of the unusually high ROE in Q3 2023 is also warranted.  The inclusion of recent news and analyst sentiment will significantly aid in a complete assessment.

**8. Recommendation:**

Based on the available data, a long-term investment in JNJ requires careful consideration. While the companyâ€™s fundamentals appear relatively solid, its recent underperformance relative to the market raises concerns.  A more in-depth analysis, including the missing data mentioned above, is necessary before making an investment decision.  Given the current market conditions and the lack of positive signals,  a cautious approach is advised.  A wait-and-see approach, closely monitoring the next earnings report and market sentiment, might be prudent before considering a long-term investment.
